John Milesi

Associate

Chicago + 1.312.269.4070

Connect:

Share

John Milesi focuses his practice on the formation, structuring, and management of investment funds, including venture capital and private equity. John also represents institutional investors such as sovereign investors, pension funds, and secondary buyers throughout the investment process, including co-investments, secondaries, separately managed accounts, and direct investments. Additionally, John has experience in mergers, acquisitions, and other strategic transactions.

Prior to law school, John was a consultant providing revenue cycle, contract, and business operational analysis to hospitals and health systems.

Experience

  • Private equity firm makes secondary purchase in private credit fundJones Day represented a private equity firm in connection with the secondary purchase of an interest in a private credit fund.
  • Global private assets manager makes purchase in private credit fundJones Day represented a global private assets manager in connection with the purchase of an interest in a private credit fund.
  • Private equity firm purchases private credit fund portfolio interestsJones Day represented a private equity firm with the purchase of a portfolio of interests in private credit funds.
  • Riverside forms RAC Opportunity Fund IIJones Day advised The Riverside Company in the formation of RAC Opportunity Fund II, L.P. ("RAC Opp Fund II"), which closed at $235 million.
  • Accord Catalyst Fund obtains subscription line credit facilityJones Day represented Accord Catalyst Fund in connection with a new subscription line credit facility.
  • Global secondaries manager purchases portfolio of private equity fund interestsJones Day represented a global secondaries manager in connection with the purchase of a portfolio of private equity fund interests
  • Riverside portfolio company acquires Jupiter Life Science Consulting (Jupiter)Jones Day advised The Riverside Company in connection with the acquisition and financing by portfolio company Red Nucleus of Jupiter Life Science Consulting (Jupiter), a leading provider of commercial and market access strategies for global pharma, biotech, and medical device companies with its primary focus in rare disease, hematology/oncology, metabolic, and neurology therapeutic areas.
  • Riverside portfolio company SureWerx acquires Footwear Specialties InternationalJones Day advised The Riverside Company in the acquisition and financing by portfolio company SureWerx of Footwear Specialties International, a leading safety footwear company.
  • Greystar acquires $2 billion portfolio from The Finger CompaniesJones Day represented Greystar Real Estate Partners LLC in connection with a $2 billion acquisition of a portfolio from The Finger Companies.
    • View All

    August 2023 Alert

    SEC Adopts Long-Awaited and Heavily Debated Private Fund Adviser Rules

    March 2022 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2022

    February 2022 Alert

    SEC's Proposed Rules Target Advisers to Private Funds

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.